nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—Metabolism of mRNA—RPL34—degenerative disc disease	0.0361	0.0361	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism of mRNA—RPL34—degenerative disc disease	0.0359	0.0359	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism of RNA—RPL34—degenerative disc disease	0.0309	0.0309	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism of RNA—RPL34—degenerative disc disease	0.0308	0.0308	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism of mRNA—RPL34—degenerative disc disease	0.0274	0.0274	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism of mRNA—RPL34—degenerative disc disease	0.0274	0.0274	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism of mRNA—RPL34—degenerative disc disease	0.0274	0.0274	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism of mRNA—RPL34—degenerative disc disease	0.027	0.027	CbGpPWpGaD
Carfilzomib—PSMB10—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0268	0.0268	CbGpPWpGaD
Carfilzomib—PSMB9—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0267	0.0267	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism of RNA—RPL34—degenerative disc disease	0.0234	0.0234	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism of RNA—RPL34—degenerative disc disease	0.0234	0.0234	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism of RNA—RPL34—degenerative disc disease	0.0234	0.0234	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism of RNA—RPL34—degenerative disc disease	0.0231	0.0231	CbGpPWpGaD
Carfilzomib—PSMB10—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.023	0.023	CbGpPWpGaD
Carfilzomib—PSMB9—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.0229	0.0229	CbGpPWpGaD
Carfilzomib—PSMB2—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0203	0.0203	CbGpPWpGaD
Carfilzomib—PSMB1—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0203	0.0203	CbGpPWpGaD
Carfilzomib—PSMB5—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0203	0.0203	CbGpPWpGaD
Carfilzomib—PSMB8—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.02	0.02	CbGpPWpGaD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.0174	0.0174	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.0174	0.0174	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.0174	0.0174	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.0172	0.0172	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CHST3—degenerative disc disease	0.0139	0.0139	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CHST3—degenerative disc disease	0.0138	0.0138	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CHST3—degenerative disc disease	0.0116	0.0116	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CHST3—degenerative disc disease	0.0116	0.0116	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—PARK2—degenerative disc disease	0.0114	0.0114	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—PARK2—degenerative disc disease	0.0113	0.0113	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CHST3—degenerative disc disease	0.0105	0.0105	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CHST3—degenerative disc disease	0.0105	0.0105	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CHST3—degenerative disc disease	0.0105	0.0105	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CHST3—degenerative disc disease	0.0104	0.0104	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—RPL34—degenerative disc disease	0.00964	0.00964	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—RPL34—degenerative disc disease	0.00959	0.00959	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—RPL34—degenerative disc disease	0.00895	0.00895	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—RPL34—degenerative disc disease	0.0089	0.0089	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CHST3—degenerative disc disease	0.00881	0.00881	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CHST3—degenerative disc disease	0.00881	0.00881	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CHST3—degenerative disc disease	0.00881	0.00881	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CHST3—degenerative disc disease	0.00869	0.00869	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—PARK2—degenerative disc disease	0.00863	0.00863	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—PARK2—degenerative disc disease	0.00863	0.00863	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—PARK2—degenerative disc disease	0.00863	0.00863	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—PARK2—degenerative disc disease	0.00851	0.00851	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—COL9A3—degenerative disc disease	0.00737	0.00737	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—COL9A3—degenerative disc disease	0.00733	0.00733	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—RPL34—degenerative disc disease	0.0073	0.0073	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—RPL34—degenerative disc disease	0.0073	0.0073	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—RPL34—degenerative disc disease	0.0073	0.0073	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—RPL34—degenerative disc disease	0.0072	0.0072	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PARK2—degenerative disc disease	0.0069	0.0069	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PARK2—degenerative disc disease	0.00687	0.00687	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—RPL34—degenerative disc disease	0.00678	0.00678	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—RPL34—degenerative disc disease	0.00678	0.00678	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—RPL34—degenerative disc disease	0.00678	0.00678	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—RPL34—degenerative disc disease	0.00668	0.00668	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—COL9A2—degenerative disc disease	0.00575	0.00575	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—COL9A2—degenerative disc disease	0.00572	0.00572	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—COL9A3—degenerative disc disease	0.00558	0.00558	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—COL9A3—degenerative disc disease	0.00558	0.00558	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—COL9A3—degenerative disc disease	0.00558	0.00558	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—COL9A3—degenerative disc disease	0.00551	0.00551	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PARK2—degenerative disc disease	0.00523	0.00523	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PARK2—degenerative disc disease	0.00523	0.00523	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PARK2—degenerative disc disease	0.00523	0.00523	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PARK2—degenerative disc disease	0.00516	0.00516	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—COL9A2—degenerative disc disease	0.00436	0.00436	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—COL9A2—degenerative disc disease	0.00436	0.00436	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—COL9A2—degenerative disc disease	0.00436	0.00436	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—COL9A2—degenerative disc disease	0.0043	0.0043	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—BMP2—degenerative disc disease	0.00383	0.00383	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—BMP2—degenerative disc disease	0.00381	0.00381	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—BMP2—degenerative disc disease	0.0029	0.0029	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—BMP2—degenerative disc disease	0.0029	0.0029	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—BMP2—degenerative disc disease	0.0029	0.0029	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—BMP2—degenerative disc disease	0.00286	0.00286	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP3—degenerative disc disease	0.00265	0.00265	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP3—degenerative disc disease	0.00264	0.00264	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CHST3—degenerative disc disease	0.00259	0.00259	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP3—degenerative disc disease	0.00201	0.00201	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP3—degenerative disc disease	0.00201	0.00201	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP3—degenerative disc disease	0.00201	0.00201	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP3—degenerative disc disease	0.00198	0.00198	CbGpPWpGaD
